Abstract Submission now closed!
Abstract Submission Deadline
The Scientific Committee of the 18th ISoP Annual Meeting invites abstracts to be submitted for either oral or poster presentation related to the subjects of pharmacovigilance and drug safety.
Abstract submission deadline extended: 11th June 2018 (10 am, CET)
Abstract Submission Guidelines
An abstract can be submitted as an Oral or Poster presentation
Abstracts must be submitted in English only
All abstracts must be submitted online via the abstract submission system
Please note that abstracts sent by mail, fax or e-mail will not be accepted
Abstracts already published elsewhere or based on full papers that have already been published will not be considered for inclusion
View Detailed Abstract Formatting Instructions Here
- Pharmacovigilance and public health
- Risk Communication in pharmacovigilance
- Benefit-Risk assessment and risk management in pharmacovigilance
- Pharmacovigilance of medical devices
- Pharmacovigilance and the pharmaceutical industry
- Patient involvement in pharmacovigilance
- Artificial intelligence/Machine learning in pharmacovigilance (or new technologies in Pharmacovigilance)
- Global pharmacovigilance
- Pharmacovigilance in resource-limited countries
- Women’s health, including contraceptive medicines and devices
- Teaching pharmacovigilance
- Signal detection
Notification of Abstract Acceptance
Abstracts will be reviewed by the ISoP 2018 Scientific Committee, and each decision will be notified to submitters by 6 July 2018. Notification of abstract acceptance or rejection will be communicated to the lead author’s e-mail address (submitter of the abstract).
Please note that if an abstract is accepted for presentation (oral or as poster), at least one of the authors (presenting author) must register for ISoP 2018. Registration should be made immediately after notification of abstract acceptance, and at least before 23rd July 2018. Presenting authors must attend the conference in order to present the abstract.
The Scientific Committee’s decisions will be based upon evaluation of the abstract’s scientific standard. The Scientific Committee will allocate each accepted abstract to the most appropriate form of presentation (oral or poster). After selection, to all presenting authors will be sent full information regarding PowerPoint preparation, poster size, style and layout, as appropriate.
Accepted abstracts, which have been received by the submission deadline, will be published in ISoP’s official journal, Drug Safety.
All accepted posters for the ISoP 2018 Annual Meeting are eligible for poster prizes which will be awarded to the three best posters.
If you have any questions regarding preparing, submitting, amending or withdrawing an abstract, please contact:
Phone: +41 22 33 99 634